These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 12625220)
1. Reducing claims for prescription drugs with a high potential for abuse. Hoffman L; Enders JL; Pippins J; Segal R Am J Health Syst Pharm; 2003 Feb; 60(4):371-4. PubMed ID: 12625220 [No Abstract] [Full Text] [Related]
2. Mixed message on prescription drug abuse. Vastag B JAMA; 2001 May; 285(17):2183-4. PubMed ID: 11325305 [No Abstract] [Full Text] [Related]
3. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds. McCarthy M BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964 [No Abstract] [Full Text] [Related]
4. Prescription Drug Monitoring Program: Useful Tool or Government Control? Lilly JD Mo Med; 2017; 114(4):234-236. PubMed ID: 30228597 [No Abstract] [Full Text] [Related]
6. From balanced pain care to drug trafficking: the case of Dr. William Hurwitz and the DEA. Fishman SM Pain Med; 2005; 6(2):162-4. PubMed ID: 15773882 [No Abstract] [Full Text] [Related]
7. Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administrators. Katz N; Houle B; Fernandez KC; Kreiner P; Thomas CP; Kim M; Carrow GM; Audet A; Brushwood D Pain Med; 2008; 9(5):587-94. PubMed ID: 18565002 [TBL] [Abstract][Full Text] [Related]
8. Interpreting and analysing practice prescribing data. Nicholls J Community Nurse; 2000 Jul; 6(6):39-42. PubMed ID: 12778649 [No Abstract] [Full Text] [Related]
9. Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed? Peckham AM; Fairman KA; Sclar DA Expert Opin Drug Saf; 2018 May; 17(5):519-523. PubMed ID: 28985090 [TBL] [Abstract][Full Text] [Related]
10. Update on Psychotropic Drug Prescribing in the United States: 2014-2015. Greenblatt DJ; Harmatz JS; Shader RI J Clin Psychopharmacol; 2018 Feb; 38(1):1-4. PubMed ID: 29215384 [No Abstract] [Full Text] [Related]
11. The challenge of prescription drug misuse: a review and commentary. Hurwitz W Pain Med; 2005; 6(2):152-61. PubMed ID: 15773881 [No Abstract] [Full Text] [Related]
13. Medicaid claims data comparisons for nurse practitioners, physician assistants, and primary care physicians in New Mexico. Birkholz G; Viens DC J Am Acad Nurse Pract; 1999 Jan; 11(1):3-10. PubMed ID: 10504916 [No Abstract] [Full Text] [Related]
15. Ethnicity and access to prescription medicines. Horsburgh S; Norris P N Z Med J; 2013 Oct; 126(1384):7-11. PubMed ID: 24162626 [No Abstract] [Full Text] [Related]
16. Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations. Fiscella RG; Lewis CC; Jensen MK Am J Health Syst Pharm; 2007 Oct; 64(19):2069-73. PubMed ID: 17893419 [TBL] [Abstract][Full Text] [Related]
17. Heart failure drugs underprescribed. Aldosterone antagonists are typically used in conjunction with other medications. Heart Advis; 2009 Dec; 12(12):6. PubMed ID: 21189516 [No Abstract] [Full Text] [Related]
18. Use of Opioid Agonist Therapy for Medicare Patients in 2013. Lembke A; Chen JH JAMA Psychiatry; 2016 Sep; 73(9):990-2. PubMed ID: 27438334 [No Abstract] [Full Text] [Related]
19. A pill problem: prescription drug abuse is the fastest growing form of substance abuse. Hanson K State Legis; 2010 Mar; 36(3):22-5. PubMed ID: 20306600 [No Abstract] [Full Text] [Related]
20. Variations in intake of tamsulosin. Chadha V; Borooah S J Cataract Refract Surg; 2007 Mar; 33(3):362-3. PubMed ID: 17321374 [No Abstract] [Full Text] [Related] [Next] [New Search]